Chronic Low Grade Inflammation in Pathogenesis of PCOS
Polycystic ovary syndrome (PCOS) is a one of the most common endocrine disorders, with a prevalence rate of 5–10% in reproductive aged women. It’s characterized by (1) chronic anovulation, (2) biochemical and/or clinical hyperandrogenism, and (3) polycystic ovarian morphology. PCOS has significant c...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-04-01
|
| Series: | International Journal of Molecular Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1422-0067/22/7/3789 |
| _version_ | 1797538667702517760 |
|---|---|
| author | Ewa Rudnicka Katarzyna Suchta Monika Grymowicz Anna Calik-Ksepka Katarzyna Smolarczyk Anna M. Duszewska Roman Smolarczyk Blazej Meczekalski |
| author_facet | Ewa Rudnicka Katarzyna Suchta Monika Grymowicz Anna Calik-Ksepka Katarzyna Smolarczyk Anna M. Duszewska Roman Smolarczyk Blazej Meczekalski |
| author_sort | Ewa Rudnicka |
| collection | DOAJ |
| description | Polycystic ovary syndrome (PCOS) is a one of the most common endocrine disorders, with a prevalence rate of 5–10% in reproductive aged women. It’s characterized by (1) chronic anovulation, (2) biochemical and/or clinical hyperandrogenism, and (3) polycystic ovarian morphology. PCOS has significant clinical implications and can lead to health problems related to the accumulation of adipose tissue, such as obesity, insulin resistance, metabolic syndrome, and type 2 diabetes. There is also evidence that PCOS patients are at higher risk of cardiovascular diseases, atherosclerosis, and high blood pressure. Several studies have reported the association between polycystic ovary syndrome (PCOS) and low-grade chronic inflammation. According to known data, inflammatory markers or their gene markers are higher in PCOS patients. Correlations have been found between increased levels of C-reactive protein (CRP), interleukin 18 (IL-18), tumor necrosis factor (TNF-α), interleukin 6 (IL-6), white blood cell count (WBC), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) in the PCOS women compared with age- and BMI-matched controls. Women with PCOS present also elevated levels of AGEs and increased RAGE (receptor for advanced glycation end products) expression. This chronic inflammatory state is aggravating by obesity and hyperinsulinemia. There are studies describing mutual impact of hyperinsulinemia and obesity, hyperandrogenism, and inflammatory state. Endothelial cell dysfunction may be also triggered by inflammatory cytokines. Many factors involved in oxidative stress, inflammation, and thrombosis were proposed as cardiovascular risk markers showing the endothelial cell damage in PCOS. Those markers include asymmetric dimethylarginine (ADMA), C-reactive protein (CRP), homocysteine, plasminogen activator inhibitor-I (PAI-I), PAI-I activity, vascular endothelial growth factor (VEGF) etc. It was also proposed that the uterine hyperinflammatory state in polycystic ovary syndrome may be responsible for significant pregnancy complications ranging from miscarriage to placental insufficiency. In this review, we discuss the most importance evidence concerning the role of the process of chronic inflammation in pathogenesis of PCOS. |
| first_indexed | 2024-03-10T12:33:44Z |
| format | Article |
| id | doaj.art-487fc0e10c1045db8da3a35ae9e8aa6b |
| institution | Directory Open Access Journal |
| issn | 1661-6596 1422-0067 |
| language | English |
| last_indexed | 2024-03-10T12:33:44Z |
| publishDate | 2021-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | International Journal of Molecular Sciences |
| spelling | doaj.art-487fc0e10c1045db8da3a35ae9e8aa6b2023-11-21T14:23:50ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-04-01227378910.3390/ijms22073789Chronic Low Grade Inflammation in Pathogenesis of PCOSEwa Rudnicka0Katarzyna Suchta1Monika Grymowicz2Anna Calik-Ksepka3Katarzyna Smolarczyk4Anna M. Duszewska5Roman Smolarczyk6Blazej Meczekalski7Department of Gynaecological Endocrinology, Medical University of Warsaw, 00-315 Warsaw, PolandDepartment of Gynaecological Endocrinology, Medical University of Warsaw, 00-315 Warsaw, PolandDepartment of Gynaecological Endocrinology, Medical University of Warsaw, 00-315 Warsaw, PolandDepartment of Gynaecological Endocrinology, Medical University of Warsaw, 00-315 Warsaw, PolandDepartment of Dermatology and Venereology, Medical University of Warsaw, 00-315 Warsaw, PolandDepartment of Morphological Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, PolandDepartment of Gynaecological Endocrinology, Medical University of Warsaw, 00-315 Warsaw, PolandDepartment of Gynaecological Endocrinology, Poznan University of Medical Sciences, 60-535 Poznan, PolandPolycystic ovary syndrome (PCOS) is a one of the most common endocrine disorders, with a prevalence rate of 5–10% in reproductive aged women. It’s characterized by (1) chronic anovulation, (2) biochemical and/or clinical hyperandrogenism, and (3) polycystic ovarian morphology. PCOS has significant clinical implications and can lead to health problems related to the accumulation of adipose tissue, such as obesity, insulin resistance, metabolic syndrome, and type 2 diabetes. There is also evidence that PCOS patients are at higher risk of cardiovascular diseases, atherosclerosis, and high blood pressure. Several studies have reported the association between polycystic ovary syndrome (PCOS) and low-grade chronic inflammation. According to known data, inflammatory markers or their gene markers are higher in PCOS patients. Correlations have been found between increased levels of C-reactive protein (CRP), interleukin 18 (IL-18), tumor necrosis factor (TNF-α), interleukin 6 (IL-6), white blood cell count (WBC), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) in the PCOS women compared with age- and BMI-matched controls. Women with PCOS present also elevated levels of AGEs and increased RAGE (receptor for advanced glycation end products) expression. This chronic inflammatory state is aggravating by obesity and hyperinsulinemia. There are studies describing mutual impact of hyperinsulinemia and obesity, hyperandrogenism, and inflammatory state. Endothelial cell dysfunction may be also triggered by inflammatory cytokines. Many factors involved in oxidative stress, inflammation, and thrombosis were proposed as cardiovascular risk markers showing the endothelial cell damage in PCOS. Those markers include asymmetric dimethylarginine (ADMA), C-reactive protein (CRP), homocysteine, plasminogen activator inhibitor-I (PAI-I), PAI-I activity, vascular endothelial growth factor (VEGF) etc. It was also proposed that the uterine hyperinflammatory state in polycystic ovary syndrome may be responsible for significant pregnancy complications ranging from miscarriage to placental insufficiency. In this review, we discuss the most importance evidence concerning the role of the process of chronic inflammation in pathogenesis of PCOS.https://www.mdpi.com/1422-0067/22/7/3789polycystic ovary syndromeinsulin resistancechronic inflammationinterleukinsCRP |
| spellingShingle | Ewa Rudnicka Katarzyna Suchta Monika Grymowicz Anna Calik-Ksepka Katarzyna Smolarczyk Anna M. Duszewska Roman Smolarczyk Blazej Meczekalski Chronic Low Grade Inflammation in Pathogenesis of PCOS International Journal of Molecular Sciences polycystic ovary syndrome insulin resistance chronic inflammation interleukins CRP |
| title | Chronic Low Grade Inflammation in Pathogenesis of PCOS |
| title_full | Chronic Low Grade Inflammation in Pathogenesis of PCOS |
| title_fullStr | Chronic Low Grade Inflammation in Pathogenesis of PCOS |
| title_full_unstemmed | Chronic Low Grade Inflammation in Pathogenesis of PCOS |
| title_short | Chronic Low Grade Inflammation in Pathogenesis of PCOS |
| title_sort | chronic low grade inflammation in pathogenesis of pcos |
| topic | polycystic ovary syndrome insulin resistance chronic inflammation interleukins CRP |
| url | https://www.mdpi.com/1422-0067/22/7/3789 |
| work_keys_str_mv | AT ewarudnicka chroniclowgradeinflammationinpathogenesisofpcos AT katarzynasuchta chroniclowgradeinflammationinpathogenesisofpcos AT monikagrymowicz chroniclowgradeinflammationinpathogenesisofpcos AT annacalikksepka chroniclowgradeinflammationinpathogenesisofpcos AT katarzynasmolarczyk chroniclowgradeinflammationinpathogenesisofpcos AT annamduszewska chroniclowgradeinflammationinpathogenesisofpcos AT romansmolarczyk chroniclowgradeinflammationinpathogenesisofpcos AT blazejmeczekalski chroniclowgradeinflammationinpathogenesisofpcos |